Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.46
+3.59 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
78.86
-1.60 (-1.99%)
After-hours: Mar 9, 2026, 7:06 PM EDT
Bright Minds Biosciences Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Selling, General & Admin | 3.07 | 2.53 | 1.45 | 2.2 | 2.55 | 2.31 | |
| Research & Development | 15.7 | 11.08 | 1.18 | 5 | 12.18 | 6.31 | |
| Operating Expenses | 18.77 | 13.61 | 2.63 | 7.2 | 14.73 | 8.62 | |
| Operating Income | -18.77 | -13.61 | -2.63 | -7.2 | -14.73 | -8.62 | |
| Interest Expense | -0.04 | -0.04 | - | - | - | - | |
| Interest & Investment Income | 2.33 | 1.52 | 0.03 | - | - | - | |
| Currency Exchange Gain (Loss) | -2.96 | 0.19 | -0.01 | 0.01 | 0.01 | 0.15 | |
| Other Non Operating Income (Expenses) | -0.4 | -0.29 | -0.2 | -0.19 | -0.24 | -0.18 | |
| EBT Excluding Unusual Items | -19.84 | -12.23 | -2.8 | -7.37 | -14.96 | -8.65 | |
| Asset Writedown | - | - | - | - | -0 | - | |
| Pretax Income | -19.84 | -12.23 | -2.8 | -7.37 | -14.96 | -8.65 | |
| Net Income | -19.84 | -12.23 | -2.8 | -7.37 | -14.96 | -8.65 | |
| Net Income to Common | -19.84 | -12.23 | -2.8 | -7.37 | -14.96 | -8.65 | |
| Shares Outstanding (Basic) | 7 | 7 | 4 | 4 | 2 | 2 | |
| Shares Outstanding (Diluted) | 7 | 7 | 4 | 4 | 2 | 2 | |
| Shares Change (YoY) | 48.78% | 59.58% | 15.87% | 50.58% | 37.64% | 148.42% | |
| EPS (Basic) | -2.73 | -1.78 | -0.65 | -1.98 | -6.06 | -4.82 | |
| EPS (Diluted) | -2.73 | -1.78 | -0.65 | -1.98 | -6.06 | -4.82 | |
| EBIT | -18.77 | -13.61 | -2.63 | -7.2 | -14.73 | -8.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.